Articles dans des revues avec comité de lecture (167)
152.
Arnould, R., Dubois, J., Abikhalil, F., Libert, A., Ghanem, G. E., Atassi, G., Hanocq, M., & Lejeune, F. (1990). Compared cytotoxicity effects of five anticancer drugs on human (HBL) and mouse (B16) melanoma cells in vitro. Anticancer research, 10, 789-794.154.
Ghanem, G. E., Verstegen, J., Libert, A., Arnould, R., & Lejeune, F. (1989). Alpha-melanocyte-stimulating hormone immunoreactivity in human melanoma metastases extracts. Pigment cell research, 2(6), 519-523.155.
Ghanem, G. E., Verstegen, J., De Rijcke, S., Hanson, P., Van Onderbergen, A., Libert, A., Del Marmol, V., Arnould, R., Vercammen Grandjean, A., & Lejeune, F. (1989). Studies on factors influencing human plasma alpha-MSH. Anticancer research, 9(6), 1691-1696.158.
Ghanem, G. E., Comunale, G., Libert, A., Vercammen Grandjean, A., & Lejeune, F. (1988). Evidence for alpha-melanocyte-stimulating hormone (alpha-MSH) receptors on human malignant melanoma cells. International journal of cancer, 41(2), 248-255. doi:10.1002/ijc.2910410216159.
Arnould, R., Ghanem, G. E., Debusschere, P., Comunale, J., Libert, A., Vercammen Grandjean, A., Ewalenko, P., & Lejeune, F. (1988). Production of interleukin 1 by activated blood monocytes and alveolar macrophages from melanoma patients. Anticancer research, 8(4), 775-779.162.
Ghanem, G. E., Lienard, D., Hanson, P., Lejeune, F., & Fruhling, J. (1986). Increased serum alpha-melanocyte stimulating hormone (alpha-MSH) in human malignant melanoma. European journal of cancer & clinical oncology, 22(4), 535-536.163.
Ghanem, G. E., Scarso, A., Degelaen, J., Vercammen, A., Atassi, G., & Lejeune, F. (1986). Targeting of human malignant melanoma with alpha melanocyte stimulating hormone (alpha MSH) coupled to melphalan. Journal of investigative dermatology, 87(3), 414.